Ultima Genomics Doubles Sequencing Output with UG200 Series Launch
Event summary
- Ultima Genomics launched the UG200 Series sequencing instruments, offering twice the output and half the runtime of its predecessor, the UG100.
- The UG200 Ultra can sequence over 60,000 whole genomes per year at 30x coverage, with a starting price of $1,250,000.
- Solaris 2.0 workflows improve genomic coverage and eliminate the need for a dedicated ePCR instrument.
- Solaris 2.0 Max, offering up to 20 billion reads per wafer, will be available in the second half of 2026.
- UG100 customers can upgrade to the UG100 Plus for nearly 4x the annual production capacity.
The big picture
Ultima Genomics' UG200 Series launch represents a significant step in the race to scale genomic sequencing, addressing the growing demand for high-throughput, cost-effective solutions. The company's focus on flexibility and automation aligns with broader industry trends toward personalized medicine and large-scale genomic studies. With the ability to sequence over 60,000 whole genomes annually, Ultima is positioning itself as a key player in enabling comprehensive cancer monitoring and global population-scale genomics.
What we're watching
- Market Adoption
- Whether the UG200 Series can attract new customers and expand Ultima's market share in high-throughput sequencing.
- Technological Integration
- The pace at which Ultima can integrate Solaris 2.0 workflows with existing lab automation systems.
- Competitive Positioning
- How Ultima's pricing and performance compare to competitors like Illumina and PacBio in the scalable genomics space.
Related topics